politics Trump Signs Order to Fast-Track Psychedelic Drug Reviews
President Trump signed an executive order Saturday directing the FDA to expedite reviews of psychedelic drugs, including ibogaine, and allocating at least $50 million to states developing psychedelic treatment programs for serious mental illness. The order was announced in the Oval Office with support from Joe Rogan, Health Secretary RFK Jr., and FDA Commissioner Marty Makary. Despite ibogaine being linked to over 30 deaths due to cardiovascular toxicity, a Stanford study found veterans treated with the drug showed improvements in PTSD, depression, and anxiety symptoms.
· United States · 4
articles